TW279861B - - Google Patents

Info

Publication number
TW279861B
TW279861B TW083101509A TW83101509A TW279861B TW 279861 B TW279861 B TW 279861B TW 083101509 A TW083101509 A TW 083101509A TW 83101509 A TW83101509 A TW 83101509A TW 279861 B TW279861 B TW 279861B
Authority
TW
Taiwan
Prior art keywords
dihydrofuran
cyclopentene
furan
cyano
nitro
Prior art date
Application number
TW083101509A
Other languages
English (en)
Chinese (zh)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of TW279861B publication Critical patent/TW279861B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW083101509A 1993-03-10 1994-02-22 TW279861B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93267A DK26793D0 (da) 1993-03-10 1993-03-10 Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling

Publications (1)

Publication Number Publication Date
TW279861B true TW279861B (fr) 1996-07-01

Family

ID=8091615

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083101509A TW279861B (fr) 1993-03-10 1994-02-22

Country Status (19)

Country Link
US (1) US5512562A (fr)
EP (1) EP0688320B1 (fr)
JP (1) JP3779319B2 (fr)
KR (1) KR960701022A (fr)
CN (1) CN1045957C (fr)
AT (1) ATE179700T1 (fr)
AU (1) AU682494B2 (fr)
CA (1) CA2157668C (fr)
DE (1) DE69418321T2 (fr)
DK (2) DK26793D0 (fr)
ES (1) ES2133542T3 (fr)
FI (1) FI111944B (fr)
GR (1) GR3030864T3 (fr)
IL (1) IL108730A (fr)
NO (1) NO953543L (fr)
NZ (1) NZ262098A (fr)
TW (1) TW279861B (fr)
WO (1) WO1994020472A1 (fr)
ZA (1) ZA941377B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2745815B1 (fr) * 1996-03-08 1998-06-26 Synthelabo Derives de benzofurane, leur preparations et compositions pharmaceutiques les comprenant
AU2030197A (en) * 1996-03-08 1997-09-22 Synthelabo 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
FR2752840A1 (fr) * 1996-08-29 1998-03-06 Synthelabo Derives de benzothiophene, leur preparation et leur application en therapeutique
AU742873B2 (en) * 1997-03-12 2002-01-17 Addex Pharma Sa Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
US6528529B1 (en) * 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
WO2000000203A1 (fr) * 1998-06-30 2000-01-06 Eli Lilly And Company Derives d'azepine jouant un role dans des systemes associes a la serotonine
JP2005522408A (ja) 2001-07-13 2005-07-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ５−ＨＴ受容体リガントとしてのヘキサヒドロアゼピノ（４，５−ｇ）インドールおよびインドリン
GB0412314D0 (en) * 2004-06-02 2004-07-07 Glaxo Group Ltd Compounds
GB0414795D0 (en) * 2004-07-01 2004-08-04 Glaxo Group Ltd Compounds
KR101781789B1 (ko) * 2010-01-27 2017-09-26 에이비 파르마 리미티드. C형 간염 바이러스 억제제로 사용되는 다환 헤테로사이클릭 화합물
KR20150108840A (ko) * 2012-12-21 2015-09-30 에이비티 홀딩 컴퍼니 세로토닌 5-ht2c 수용체 리간드로서 벤즈아제핀 및 그의 용도
CN105566262B (zh) * 2016-01-11 2017-10-27 华东理工大学 苯并呋喃‑7‑烷基胺类化合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255445A (en) * 1980-03-07 1981-03-10 Smithkline Corporation 8-Hydroxy-6,7-(2-methyl-2,3-dihydrofuro)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
CA1234110A (fr) * 1983-08-12 1988-03-15 Joel G. Berger Derives de benzazepine, composes pharmaceutiques les contenant et procede de preparation de tels composes
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
DK157925C (da) * 1985-04-22 1990-08-27 Novo Industri As 2,3,4,5-tetrahydro-1h-3-benzazepinderivater og farmaceutiske praeparater indeholdende disse

Also Published As

Publication number Publication date
CA2157668C (fr) 2006-05-30
DK26793D0 (da) 1993-03-10
FI954229A0 (fi) 1995-09-08
JPH08507498A (ja) 1996-08-13
AU6138694A (en) 1994-09-26
ES2133542T3 (es) 1999-09-16
NO953543D0 (no) 1995-09-08
DE69418321T2 (de) 1999-12-30
CA2157668A1 (fr) 1994-09-15
FI111944B (fi) 2003-10-15
NO953543L (no) 1995-09-08
KR960701022A (ko) 1996-02-24
AU682494B2 (en) 1997-10-09
DE69418321D1 (de) 1999-06-10
EP0688320A1 (fr) 1995-12-27
US5512562A (en) 1996-04-30
CN1045957C (zh) 1999-10-27
ZA941377B (en) 1995-08-28
IL108730A (en) 1999-08-17
EP0688320B1 (fr) 1999-05-06
DK0688320T3 (da) 1999-11-01
IL108730A0 (en) 1994-05-30
GR3030864T3 (en) 1999-11-30
NZ262098A (en) 1996-11-26
FI954229A (fi) 1995-09-08
WO1994020472A1 (fr) 1994-09-15
JP3779319B2 (ja) 2006-05-24
ATE179700T1 (de) 1999-05-15
CN1121710A (zh) 1996-05-01

Similar Documents

Publication Publication Date Title
TW279861B (fr)
EP1020445A4 (fr) Derives de pyridine condenses
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
MY136270A (en) Processes and intermediates for preparing anti-cancer compounds
ZA982134B (en) Therapeutic agents.
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
CA2269994A1 (fr) Hetero-7-bicyclo-heptanes-2.2.1
ES2193158T3 (es) Compuestos tetraciclicos agonistas de la dopamina.
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
ES8706159A1 (es) Procedimiento para la fabricacion de nuevos antibioticos de b-lactama
IL105464A0 (en) 1-piperazino-1,2-dihydroindene derivatives
GB9306886D0 (en) Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
BG108193A (en) Pregabalin lactose conjugates
ZA971670B (en) Aminotetralin derivatives and compositions and method of use thereof.
TR199900527T2 (xx) N�rolojik bozukluklar�n tedavisi i�in benzopiranollerin kullan�m�.
MY111699A (en) Isoquinoline derivatives as therapeutic agents
NZ536524A (en) Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
TW334428B (en) Novel benzodiazepine derivatives
AP2002002595A0 (en) Heterocyclic amide derivatives.
EP0769496A4 (fr) Nouveau derive de 2,3-dihydrobenzofuranne, son procede de production et son utilisation
JO1815B1 (en) Therapeutic agents